Transcode Therapeutics reported cash from operations of -$5.40M and free cash flow of -$5.40M for the quarter ended Jun 2026, down 28.7% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||
| Net Income | -2.36M | -2.99M | -3.48M | -4.71M | -4.94M | -5.49M | -4.90M | -5.13M | -5.33M | -4.11M | -3.30M | -5.12M | -2.18M | -5.09M | -12.09M | -4.28M | -4.57M | -15.95M | -17.55M | -6.75M | |||||
| Share-based Compensation | 1.79M | 0.04M | 2.09M | 2.12M | 2.12M | 0.13M | 3.02M | 0.27M | 0.39M | 0.31M | 0.18M | 1.94M | 1.92M | 0.17M | 0.16M | 0.00M | 0.15M | 0.06M | 0.00M | 0.00M | |||||
| Gains from Investment Securities | 0.00M | 9.23M | 0.16M | 0.28M | -0.40M | 0.13M | -0.23M | ||||||||||||||||||
| Cash from Operations | -3.07M | -1.60M | -3.95M | -3.37M | -4.42M | -4.02M | -4.51M | -4.39M | -3.51M | -5.66M | -3.94M | -2.34M | -3.91M | -3.15M | -3.10M | -4.19M | -4.11M | -8.12M | -5.00M | -5.40M | |||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.07M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.11M | 0.04M | ||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 0.03M | 0.02M | 0.02M | 0.02M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.03M | 0.02M | 0.01M | 0.01M | 0.01M | 0.00M | -0.02M | 0.02M | 0.02M | ||||||
| Change in Working Capital | |||||||||||||||||||||||||
| Change in Accured Expenses | 1.50M | 0.52M | -0.68M | -0.12M | 2.03M | 0.61M | 0.58M | -1.74M | 1.96M | -2.09M | -0.68M | 0.91M | -1.14M | 0.58M | -0.20M | -0.94M | 1.40M | -0.04M | 1.77M | -0.59M | |||||
| Other Working Capital Changes | 2.24M | -0.80M | -0.12M | -1.33M | 1.84M | -0.24M | 0.67M | -1.40M | 0.45M | -0.14M | 0.11M | -0.77M | 0.36M | -0.11M | -0.13M | -0.46M | 1.03M | -0.91M | 0.70M | 0.64M | |||||
| Investing Activities | |||||||||||||||||||||||||
| Capital Expenditures | 0.07M | 0.09M | 0.03M | 0.04M | 0.03M | 0.01M | 0.02M | 0.00M | 0.00M | 0.00M | 0.01M | 500.00 | |||||||||||||
| Cash from Investing Activities | -0.07M | -0.08M | -0.03M | -0.04M | -0.03M | -0.01M | -0.02M | -0.00M | -0.00M | -0.00M | -0.01M | -500.00 | |||||||||||||
| Financing Activities | |||||||||||||||||||||||||
| Other financing activities | 0.01M | ||||||||||||||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||
| Shares Issued | 679.00 | 0.04M | 0.83M | 0.83M | 0.92M | 1.21M | 1.21M | ||||||||||||||||||
| Net Shares Issued and Repurchased | 0.08M | 0.45M | 0.00M | 0.00M | 89.00 | 414.00 | 0.00M | 464.00 | 67.00 | ||||||||||||||||
| Net Equity Issued and Repurchased | 1.18M | 7.16M | 0.90M | 0.98M | 6.09M | 0.79M | 2.45M | 7.08M | 8.85M | 13.81M | |||||||||||||||
| Misc. | |||||||||||||||||||||||||
| Cash from Financing Activities | 25.56M | 0.01M | 0.01M | -0.23M | 0.23M | 1.18M | 6.36M | 7.39M | 0.98M | 6.09M | 0.79M | 2.45M | 7.08M | 8.85M | -0.46M | 23.12M | |||||||||
| Change in Cash | 22.42M | -1.67M | -3.97M | -3.41M | -4.65M | -3.82M | -3.35M | 1.95M | 3.88M | -4.69M | 2.15M | -1.56M | -1.48M | 3.94M | 5.76M | -4.19M | -4.54M | 14.98M | -4.98M | -4.45M | |||||
| Free Cash Flow | -3.14M | -1.69M | -3.98M | -3.41M | -4.42M | -4.05M | -4.53M | -4.41M | -3.51M | -5.66M | -3.94M | -2.34M | -3.93M | -3.15M | -3.10M | -4.19M | -4.11M | -8.12M | -5.00M | -5.40M | |||||
| Net Cash Flow | 22.42M | -1.67M | -3.97M | -3.41M | -4.65M | -3.82M | -3.35M | 1.95M | 3.88M | -4.69M | 2.15M | -1.56M | -1.48M | 3.94M | 5.76M | -4.19M | -4.56M | 15.01M | -5.00M | -5.40M |